Top-selling drug in America has more than 140,000 bottles recalled


This recording was made using enhanced software.

Summary

Scope of recall

More than 140,000 bottles of a drug used to treat high cholesterol have been recalled.

Defect

Officials say the batches in question potentially have pills that do not properly dissolve, impacting effectiveness.

What should impacted patients do?

Officials advise patients with impacted prescriptions to contact a medical expert and have the pills swapped out for effective medication.


Full story

More than 140,000 bottles of a popular prescription medication used to treat high cholesterol have been recalled because of a flaw that may limit the effectiveness of the drug. Ascend Laboratories, the company that distributes the medication, first recalled its atorvastatin calcium tablets on Sept. 19, but last month changed the recall to a “Class II” status, which means health officials suspect that use of the medication could lead to temporary or reversible side effects.

Atorvastatin is the generic form of Lipitor. It is reportedly the most-prescribed drug in the United States and is meant to reduce bad cholesterol, decreasing the risk of a heart attack.

QR code for SAN app download

Download the SAN app today to stay up-to-date with Unbiased. Straight Facts™.

Point phone camera here

The reported defect

The recalled pills failed to pass a quality control test, according to Ascend Laboratories. The samples of the medication, which were taken between November 2024 and September 2025, did not dissolve as intended. That’s a problem, as medical professionals say the pill must dissolve properly in order for the active ingredients to be absorbed by the body and work effectively. That also means an increased risk of heart problems.

“So, while patients wouldn’t immediately feel a difference if their atorvastatin tablets didn’t dissolve properly, their risk of cardiovascular events would significantly rise,” Dr. C. Michael White, who works at the Department of Pharmacy Practice at UConn, explains in an article for The Conversation.

The impacted drugs include bottles of 10 mg, 20 mg, 40 mg and 80 mg of the atorvastatin calcium tablets made by India-based Alkem Laboratories and distributed by Ascend.

What to look for

White urges people to examine their prescription labels for the following abbreviations. He said MFG stands for “manufacturing” or MFR for “manufacturer.” White said a label that reads: “MFG Ascend” may potentially indicate the medication is part of the company’s recalled batches.

Unbiased. Straight Facts.TM

Atorvastatin is the top selling drug in the United States with more than 115 million reported prescriptions for more than 29 million Americans.

Advice for those with impacted bottles

He added that if a patient discovers these labels on the bottle, they should call a pharmacist to determine if the pills are part of the recalled batch. If recalled, a patient can have their pills swapped out for a different medication that isn’t under recall, according to White.

Unlike other recalls, the Food and Drug Administration (FDA) does not want people to throw the medication out if it’s an affected prescription.

“In some instances, stopping your medicine may be more harmful to your health than continuing to take the recalled medicine,” the FDA states.

The agency stated that even if the effectiveness of the medication is impacted, taking the prescribed medication is better than not taking anything at all, and also reiterated that a pharmacist can assist patients with replacements for their medication.

Mathew Grisham (Digital Producer) contributed to this report.
Tags: , , ,

SAN provides
Unbiased. Straight Facts.

Don’t just take our word for it.


Certified balanced reporting

According to media bias experts at AllSides

AllSides Certified Balanced May 2025

Transparent and credible

Awarded a perfect reliability rating from NewsGuard

100/100

Welcome back to trustworthy journalism.

Find out more

Why this story matters

A recall of over 140,000 bottles of a widely prescribed cholesterol medication may affect patient health, as improper dissolution of the tablets could reduce drug effectiveness and increase cardiovascular risks for those affected.

Medication effectiveness

According to Ascend Laboratories, the manufacturing issue led to tablets that may not dissolve properly, which medical professionals say is essential for the medication’s efficacy and patient safety.

Patient guidance

The FDA and medical experts emphasize the importance of consulting pharmacists and not discontinuing medication abruptly, as stopping treatment could pose greater health risks than the identified issue.

SAN provides
Unbiased. Straight Facts.

Don’t just take our word for it.


Certified balanced reporting

According to media bias experts at AllSides

AllSides Certified Balanced May 2025

Transparent and credible

Awarded a perfect reliability rating from NewsGuard

100/100

Welcome back to trustworthy journalism.

Find out more

Media landscape

Click on bars to see headlines

10 total sources

Key points from the Left

No summary available because of a lack of coverage.

Report an issue with this summary

  • No coverage from Far Left sources 0 sources
  • No coverage from Left sources 0 sources
  • No coverage from Lean Left sources 0 sources

Key points from the Right

No summary available because of a lack of coverage.

Report an issue with this summary

Other (sources without bias rating):

  • No coverage from Other sources 0 sources

Powered by Ground News™

Daily Newsletter

Start your day with fact-based news

Start your day with fact-based news

Learn more about our emails. Unsubscribe anytime.

By entering your email, you agree to the Terms and Conditions and acknowledge the Privacy Policy.